Prevalence of financial toxicity and its association with medication adherence among patients undergoing haemodialysis under comprehensive public support in Japan
- 1 March 2026
- journal article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (2) , 353-363
Abstract
Background: Beyond affordability, financial strain can induce psychological stress and a sense of financial distress, collectively termed “financial toxicity”. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of financial toxicity and its effects on medication adherence. This study aimed to assess the prevalence of financial toxicity and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods: This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. Financial toxicity and self-reported medication adherence were assessed using the Comprehensive Score for Financial Toxicity (COST) and the 12-item Adherence Starts with Knowledge (ASK-12) scale, respectively. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. A mediation analysis was conducted to explore potential pathways underlying this association. Results: In total, 455 participants were included. The mean COST score was 22.0, and 68.5% of the participants experienced at least mild financial toxicity. Financial toxicity severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower financial toxicity (higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = −.17). The mediation analysis suggested that emotional impact represents one pathway linking financial toxicity to adherence difficulties. Conclusions: Despite generous public coverage, financial toxicity is common among Japanese patients undergoing haemodialysis and is associated with subjective difficulties in medication adherence.Keywords
Funding Information
- JSPS KAKENHI (JP19KT0021)
- JSPS KAKENHI (JP23K16271)
This publication has 26 references indexed in Scilit:
- Financial toxicity in patients with chronic kidney disease undergoing peritoneal dialysisInterdisciplinary Nursing Research, 2024
- Patient-Centered Quality Measures for Dialysis Care: A Report of a Kidney Disease Outcomes Quality Initiative (KDOQI) Scientific Workshop Sponsored by the National Kidney FoundationAmerican Journal of Kidney Diseases, 2023
- The Cognitive Burden of Poverty: A Mechanism of Socioeconomic Health DisparitiesAmerican Journal of Preventive Medicine, 2022
- Identifying missing links in the conceptualization of financial toxicity: a qualitative studySupportive Care in Cancer, 2021
- Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literatureInternational Urology and Nephrology, 2020
- Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative researchClinical Kidney Journal, 2017
- The development of a financial toxicity patient‐reported outcome in cancer: The COST measureCancer, 2014
- Measuring functional health among the elderlyInternational Journal of Rehabilitation Research, 2014
- Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipientsKidney International, 2009
- Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis providerNephrology Dialysis Transplantation, 2004